CpG-depleted plasmid DNA vectors with enhanced safety and long-term gene expression in vivo.


Systemic delivery of cationic lipid-plasmid DNA (pDNA) complexes induces an acute inflammatory response with adverse hematologic changes and liver damage. Immunostimulatory CpG motifs in the pDNA are known to contribute substantially to this response. Here we constructed a pDNA vector (pGZB) that has been depleted of 80% of the CpG motifs present in the original vector. Compared with the unmodified vector, systemic administration of pGZB induced considerably fewer changes in blood parameters, reduced levels of inflammatory cytokines, and decreased liver damage. Despite the extensive sequence modifications within pGZB, there were still robust levels of transgene expression. Furthermore, in contrast to the transient expression observed from the unmodified vector, we observed sustained or increasing expression for up to 49 days from pGZB in the lung and liver of immunocompetent BALB/c mice. Studies adding CpG motifs in trans or in cis indicate that the reduced CpG content of pGZB was the major determinant for its persistent expression. This combination of decreased toxicity and sustained expression suggests that CpG-depleted pDNA vectors can greatly improve the safety and efficacy of synthetic gene delivery systems.

Citations per Year

1,988 Citations

Semantic Scholar estimates that this publication has 1,988 citations based on the available data.

See our FAQ for additional information.

Cite this paper

@article{Yew2002CpGdepletedPD, title={CpG-depleted plasmid DNA vectors with enhanced safety and long-term gene expression in vivo.}, author={Nelson S. Yew and Hongmei Zhao and Malgorzata Przybylska and I-Huan Wu and Jennifer D Tousignant and Ronald K. Scheule and Seng H . Cheng}, journal={Molecular therapy : the journal of the American Society of Gene Therapy}, year={2002}, volume={5 6}, pages={731-8} }